Please ensure Javascript is enabled for purposes of website accessibility

Why Edwards Lifesciences Shares Got Crushed

By Brian D. Pacampara, CFA - Apr 24, 2013 at 1:23PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Is this meaningful? Or just another movement?

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Edwards Lifesciences (EW 2.59%) plummeted 22% today after the heart valve maker's quarterly results and outlook missed Wall Street expectations.

So what: Edwards' first quarter results -- adjusted EPS of $0.72 on revenue of $496.7 million versus the consensus of $0.76 and $519 million, respectively -- and downbeat guidance for the full year reinforce recent concerns over slowing growth going forward. Specifically, sales of the company's new Sapien heart valves just aren't growing as quickly as the stock's seemingly lofty P/E requires, forcing analysts to recalibrate their expectations yet again.

Now what: Management now sees full-year adjusted EPS of $3.00-$3.10 on sales of $2 billion-$2.1 billion, below Wall Street's view of $3.27 and $2.14 billion, respectively.

"We remain committed to our high level of investment in our pipeline of new products ... and now project R&D to be 16 percent of sales in 2013," said Chairman and CEO Michael Mussallem. "We believe this enables us to aggressively develop our innovative product lines, driving long term growth and extending our leadership position in structural heart therapies and critical care technologies." More important, with the stock hitting a new 52-week low today and trading at a forward P/E in the mid-teens, the valuation might finally be low enough to gain from that progress.

Interested in more info on Edwards? Add it to your watchlist. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Edwards Lifesciences Corporation Stock Quote
Edwards Lifesciences Corporation
EW
$101.12 (2.59%) $2.55

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
344%
 
S&P 500 Returns
120%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.